BGMD.US BG Medicine Inc

Healthcare Life Sciences Tools & Services USA Stocks
0.0001 USD
Close of Nov 14, 2026
0.0001 0.0001
Market cap
USD 1.14K
P/E
-
P/B
-
ROE
-
Dividend yield
219,876.87%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2022.

Is BGMD.US undervalued?

Graham number

The Graham number of BG Medicine Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BG Medicine Inc fundamental analysis

No fundamental analysis for BG Medicine Inc yet.

BG Medicine Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BG Medicine Inc

BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, In…

Full company profile